Neurology News and Research

Latest Neurology News and Research

AHA/ASA honors UCLA Medical Center with Get With The Guidelines-Stroke award

Ronald Reagan UCLA Medical Center has received the American Heart Association/American Stroke Association's Get With The Guidelines-Stroke Gold Plus Quality Achievement Award.

25 Oct 2012

Kessler Foundation expert to study effects of prism adaptation therapy for spatial neglect

A.M. Barrett, MD, of Kessler Foundation received a grant totaling $595,756 to study the effects of prism adaptation therapy for spatial neglect in survivors of right-sided stroke.

25 Oct 2012

Meningitis outbreak spreads; Mass. revokes Compounding Center's license

The Massachusetts Board of Pharmacy has permanently revoked the license of the New England Compounding Center, the facility implicated in a nationwide outbreak of fungal meningitis, Gov. Deval Patrick announced Tuesday. ... State Director of Healthcare Safety Madeleine Biondolillo said ... investigators witnessed "black particulate matter" in some vials of medicine returned amid the nationwide recall of NECC's products.

25 Oct 2012

Scientists create new compounds that could slow progression of Parkinson's

In an early-stage breakthrough, a team of Northwestern University scientists has developed a new family of compounds that could slow the progression of Parkinson's disease.

25 Oct 2012

ACIS Anterior Cervical Interbody Spacer System launched by DePuy Synthes Spine

DePuy Synthes Spine today announced the launch of the ACIS Anterior Cervical Interbody Spacer System (ACIS System), a comprehensive set of spacers and instrumentation for anterior cervical discectomy and fusion (ACDF).

24 Oct 2012

New U-M mobile phone app for concussion patients

A new mobile phone app, the first of its kind, helps concussion patients track their activities and symptoms, and share that information with their healthcare team. The app from the University of Michigan, is called Return2Play.

24 Oct 2012

Bayer announces data from riociguat Phase III trial on CTEPH

Bayer HealthCare today announced data from the Phase III CHEST-1 trial evaluating its investigational drug riociguat in patients with inoperable chronic thromboembolic pulmonary hypertension (CTEPH) or with persistent or recurrent pulmonary hypertension (PH) after surgery.

24 Oct 2012

SUNY Downstate to join Neurological Emergencies Treatment Trials network

SUNY Downstate Medical Center has been selected by the National Institutes of Health (NIH) to join the Neurological Emergencies Treatment Trials (NETT) network, which is dedicated to improving emergency care for neurological injuries that require immediate care, such as stroke, seizures, and traumatic brain injury, as well as other illnesses affecting the brain, spinal cord, and peripheral nervous system.

24 Oct 2012

Study still implicates amyloid beta in causing Alzheimer's dementia

Researchers at Washington University School of Medicine in St. Louis have found a key difference in the brains of people with Alzheimer's disease and those who are cognitively normal but still have brain plaques that characterize this type of dementia.

23 Oct 2012

Exercise may protect the brain from age-related changes

People who exercise later in life may better protect their brain from age-related changes than those who do not, a study suggests.

23 Oct 2012

Eisai receives FDA approval for Fycompa to treat partial onset seizures

The U.S. Food and Drug Administration today approved Fycompa (perampanel) tablets to treat partial onset seizures in patients with epilepsy ages 12 years and older.

23 Oct 2012

Medicare's policy on compounded drugs under scrutiny; Lawsuits growing in meningitis outbreak

The Associated Press reports on the role Medicare plays in national drug purchasing and The Washington Post finds the "race is on" to sign up clients for lawsuits.

22 Oct 2012

Cedars-Sinai Medical Center honored with national consumer award

For the 17th year in a row, Cedars-Sinai Medical Center has been honored with a national consumer award for having the best overall healthcare quality, doctors and nurses in the Los Angeles area based on an independent survey of households.

22 Oct 2012

VEGF produced by NPCs plays a strong role in influencing microglial behavior

The brain's key "breeder" cells, it turns out, do more than that. They secrete substances that boost the numbers and strength of critical brain-based immune cells believed to play a vital role in brain health. This finding adds a new dimension to our understanding of how resident stem cells and stem cell transplants may improve brain function.

22 Oct 2012

Bayer announces data from riociguat Phase III pulmonary arterial hypertension trial

Bayer HealthCare today announced data from the Phase III PATENT-1 pulmonary arterial hypertension (PAH) trial evaluating its investigational drug riociguat in both treatment-naive patients and those pre-treated with an endothelin receptor antagonist or an oral, inhaled or subcutaneous prostanoid.

22 Oct 2012

Leaders come together to discuss latest advances in neurosciences

Stony Brook Medicine's Neurosciences Institute brings together leaders in the field of neurosciences to present the latest advances in research and clinical care for neurodegenerative disorders, neuropsychiatric disorders, and neuro-ophthalmology.

20 Oct 2012

UCI, Brown work advances quest for novel treatments for inherited disorder

UC Irvine and Brown University researchers have created a new fruit fly model of inherited epilepsy that's providing insights into the mechanisms underlying temperature-dependent seizures while establishing a platform from which to develop therapies for these disorders.

20 Oct 2012